Citius Pharmaceuticals
CTXR
#10104
Rank
A$12.59 M
Marketcap
$1.35
Share price
2.14%
Change (1 day)
-95.45%
Change (1 year)

Earnings for Citius Pharmaceuticals (CTXR)

Earnings in 2024 (TTM): -A$60.39 Million

According to Citius Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$58.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Citius Pharmaceuticals from 2011 to 2024

Annual earnings

Year Earnings Change
2024 -A$62.24 Million5.78%
2023 -A$58.84 Million37.8%
2022 -A$42.7 Million13.08%
2021 -A$37.76 Million12.91%
2020 -A$33.44 Million33.5%
2019 -A$25.05 Million21.61%
2018 -A$20.6 Million14.93%
2017 -A$17.93 Million23.83%
2016 -A$14.48 Million180.39%
2015 -A$5.17 Million
2013 -A$0.89 Million2605.74%
2012 -A$0.04 Million4.81%
2011 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 259.22%๐Ÿ‡บ๐Ÿ‡ธ USA